Friday, July 10, 2026

pharma · Pain

Guangzhou General Hospital

Guangzhou General Hospital clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Intelligence · Clinical Programs

Guangzhou General Hospital projects

1 ClinicalTrials.gov programs sponsored by Guangzhou General Hospital.

Guangzhou General Hospital has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 0.33% ropivacaine 250ml

    Guangzhou General Hospital of Guangzhou Military Command

    Pain

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Guangzhou General Hospital have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.